Company / SG&A Expense
HCA Healthcare SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$548.0M
FY2025
5-year range
$307.0M / $548.0M
FY2021-FY2025
Trend
+30.2%
vs FY2024
Sector context
#65 of 158
Health Care
What the data says
At $548M, HCA Healthcare's sg&a expense ranks #94 of 158 in the Health Care sector. SG&A Expense has increased for 3 consecutive years, from $307M in FY2022 to $548M in FY2025.
Based on SEC 10-K filings.
$548M in FY2025 with a 5-year CAGR of +5.7%.
Increased from $337M to $548M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +21.3%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
#94 of 158 in Health CareTop 59% of 158This company $548.0M Sector average $175.9B
▼
-99.7% below sector average
Key checks
Key Insights
- HCA Healthcare's sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +5.7%, indicating consistent growth.
- In FY2025, sg&a expense increased 30.2% year-over-year.
- Ranks #65 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $548.0M | +30.2% |
| FY2024 | $421.0M | +24.9% |
| FY2023 | $337.0M | +9.8% |
| FY2022 | $307.0M | -8.9% |
| FY2021 | $337.0M | -19.0% |
| FY2020 | $416.0M | +12.4% |
| FY2019 | $370.0M | +7.6% |
| FY2018 | $344.0M | +1.2% |
| FY2017 | $340.0M | -0.9% |
| FY2016 | $343.0M | +4.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026